FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

cobas liat Bordetella panel nucleic acid test

K Number: K243753 · Decision Nov 20, 2025
Classifications
1
FEI Numbers
13
Registration Numbers
13
Same Product Code
8
Applicant Total
51
Review Days
350

Basic Information

Device Name
cobas liat Bordetella panel nucleic acid test
K Number
K243753
Device Class
FDA class 2
Clearance Type
Dual Track
Regulation Number
866.3980
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Roche Molecular Systems, Inc.
Date Received
December 5, 2024
Decision Date
November 20, 2025
Product Code
OZZ
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OZZ Bordetella Pertussis Dna Assay System

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (OZZ), ordered by most recent decision date.

View all

Other Clearances by Roche Molecular Systems, Inc.

K Number Device Name
K253756 cobas liat CT/NG nucleic acid test
K253759 cobas liat CT/NG/MG nucleic acid test
K252484 cobas HCV
K252481 cobas CMV
K243455 cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 Systems
K243863 Opulus™ Lymphoma Precision
K243400 cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test
K243406 cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test
K243346 cobas liat SARS-CoV-2 v2 nucleic acid test
K240867 cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems
Search all 51 clearances from Roche Molecular Systems, Inc. →